Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.

Summary: Ovarian cancer is often called the "silent killer" because it is hard to detect early. In a new study, researchers investigated whether testing for specific proteins in the blood—called Angiopoietin-1 and Ang-2—could help doctors understand the severity of the disease. These proteins are involved in building blood vessels, which tumors need to grow. The study found that Ang-2 levels were significantly higher in women with ovarian cancer compared to those with benign tumors or healthy ovaries. Most importantly, high levels of Ang-2 served as a warning sign: they predicted advanced cancer stages, larger tumors remaining after surgery, and lower survival rates. While the standard test (CA-125) is still better for initial diagnosis, measuring Ang-2 could provide crucial information about a patient's long-term outlook.